On September 11, 2026, the Symbiosis cross-chain protocol was attacked, allowing an attacker to mint about 46 to 369 billion synthetic Bitcoin tokens (syBTC) without backing, causing a real loss of roughly $336,000. The vulnerability was due to poor message verification in the BridgeV2 contract, enabling fake token creation. Symbiosis halted deposits of Bitcoin into the bridge but kept withdrawals operational, allowing users to still access their balances in one direction. Users are advised to check their synthetic token holdings, test withdrawals with small amounts, revoke unnecessary token approvals, and consider holding Bitcoin in hardware wallets or regulated platforms to avoid similar risks. The incident highlights the risks of cross-chain bridges compared to holding Bitcoin directly on its native blockchain.
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a new AI-powered tactical assistant designed to support naval operations by providing enhanced visualizations, automated analyses, and mission-specific recommendations. This system helps naval off...
Investec Bank plc, acting as joint broker for Pollen Street Group Limited, disclosed share transactions on October 26, 2026. The bank purchased and sold 20,765 ordinary shares at prices ranging from 929 to 935 per share. There were no derivative tran...
Investec Bank Plc, acting as financial adviser to DBAY Advisors Limited, purchased 50,000 ordinary shares of Logistics Development Group plc on October 26, 2026, at a price of 21.5 per share. This transaction was disclosed under Rule 8.5 of the Takeo...
